Third-party blood stem cell transplantation as a factor to impact on poor graft function

When a research team in China evaluated the efficacy and safety of using mesenchymal stem cells expanded from the bone marrow of non-self-donors to treat patients experiencing poor graft function after receiving transplants of non-self-donated blood stem cells , they found that the mesenchymal stem cells were both safe and effective for treating ... (more)

http://www.eurekalert.org/pub_releases/2013-03/ctco-tbs031813.php